BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37127928)

  • 1. Reliability of assessing morphologic features with prognostic significance in cytology specimens of epithelioid diffuse pleural mesothelioma and implications for cytopathology reporting.
    Li Y; Salama AM; Baine MK; Bodd FM; Offin MD; Rekhtman N; Zauderer MG; Travis WD; Adusumilli PS; Sauter JL
    Cancer Cytopathol; 2023 Aug; 131(8):495-506. PubMed ID: 37127928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Nuclear Grade, Necrosis, and Histologic Subtype Between Biopsy and Resection in Pleural Malignant Mesothelioma: An International Multi-Institutional Analysis.
    Schulte JJ; Chapel DB; Attanoos R; Brcic L; Burn J; Butnor KJ; Chang N; Chen H; Dacic S; De Perrot M; Fukuoka J; Galateau-Salle F; Godschachner T; Hiroshima K; Klebe S; Krausz T; Litzky L; Marchevsky AM; Mueller J; Nabeshima K; Nicholson AG; Pal P; Roden AC; Rorvig S; Santoni-Rugiu E; Tazelaar H; Tsao MS; Walts AE; Weynand B; Zaizen Y; Zhang YZ; Husain AN
    Am J Clin Pathol; 2021 Nov; 156(6):989-999. PubMed ID: 33978147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Critical Assessment of Current Grading Schemes for Diffuse Pleural Mesothelioma With a Proposal for a Novel Mesothelioma Weighted Grading Scheme (MWGS).
    Fuchs TL; Chou A; Aksoy Y; Mahjoub M; Sheen A; Sioson L; Ahadi M; Gill AJ
    Am J Surg Pathol; 2022 Jun; 46(6):774-785. PubMed ID: 34907994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study.
    Rosen LE; Karrison T; Ananthanarayanan V; Gallan AJ; Adusumilli PS; Alchami FS; Attanoos R; Brcic L; Butnor KJ; Galateau-Sallé F; Hiroshima K; Kadota K; Klampatsa A; Stang NL; Lindenmann J; Litzky LA; Marchevsky A; Medeiros F; Montero MA; Moore DA; Nabeshima K; Pavlisko EN; Roggli VL; Sauter JL; Sharma A; Sheaff M; Travis WD; Vigneswaran WT; Vrugt B; Walts AE; Tjota MY; Krausz T; Husain AN
    Mod Pathol; 2018 Apr; 31(4):598-606. PubMed ID: 29327706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma.
    Kadota K; Suzuki K; Colovos C; Sima CS; Rusch VW; Travis WD; Adusumilli PS
    Mod Pathol; 2012 Feb; 25(2):260-71. PubMed ID: 21983936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic features predict survival in diffuse pleural malignant mesothelioma on pleural biopsies.
    Habougit C; Trombert-Paviot B; Karpathiou G; Casteillo F; Bayle-Bleuez S; Fournel P; Vergnon JM; Tiffet O; Péoc'h M; Forest F
    Virchows Arch; 2017 Jun; 470(6):639-646. PubMed ID: 28349237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of prognostic histological parameters proposed for pleural mesothelioma in diffuse malignant peritoneal mesothelioma. A short report.
    Pezzuto F; Vimercati L; Fortarezza F; Marzullo A; Pennella A; Cavone D; Punzi A; Caporusso C; d'Amati A; Lettini T; Serio G
    Diagn Pathol; 2021 Jul; 16(1):64. PubMed ID: 34294087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of pleomorphic features but not growth patterns improves prognostic stratification of epithelioid malignant pleural mesothelioma by 2-tier nuclear grade.
    Zhang YZ; Brambilla C; Molyneaux PL; Rice A; Robertus JL; Jordan S; Lim E; Lang-Lazdunski L; Begum S; Dusmet M; Anikin V; Beddow E; Finch J; Asadi N; Popat S; Quesne JL; Husain AN; Cookson WOCM; Moffatt MF; Nicholson AG
    Histopathology; 2020 Sep; 77(3):423-436. PubMed ID: 32333813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updates on grading mesothelioma.
    Schulte JJ; Husain AN
    Histopathology; 2024 Jan; 84(1):153-162. PubMed ID: 37872123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter study of diffuse pleural mesothelioma. Histopathological and immunohistochemical features.
    Poleri C; Acosta Haab G; Falcoff N; Guman G; Dalurzo L; Iotti A; Martín ME; Olmedo G; Rayá M; Reginatto A; Werbach A; Demelli G; Labanca MJ; Leguina L; Mora MF
    Medicina (B Aires); 2022; 82(2):210-216. PubMed ID: 35417384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher concordance of PD-L1 expression between biopsies and effusions in epithelioid than in nonepithelioid pleural mesothelioma.
    Mansour MSI; Seidal T; Mager U; Dobra K; Brunnström H; Dejmek A
    Cancer Cytopathol; 2021 Jun; 129(6):468-478. PubMed ID: 33493383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma.
    Mansour MSI; Huseinzade A; Seidal T; Hejny K; Maty A; Taheri-Eilagh F; Mager U; Dejmek A; Dobra K; Brunnström H
    Cytopathology; 2023 Sep; 34(5):456-465. PubMed ID: 37337638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma.
    Chirieac LR; Hung YP; Foo WC; Hofer MD; VanderLaan PA; Richards WG; Sugarbaker DJ; Bueno R
    Cancer; 2019 Dec; 125(23):4164-4171. PubMed ID: 31390057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Updates in the pathological diagnosis of Pleural Malignant Mesothelioma in the WHO classification of thoracic tumors (5(th) edition)].
    Piao ZH; Zhou XC; Zhang X
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2022 Dec; 40(12):956-960. PubMed ID: 36646495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility of histological subtyping of malignant pleural mesothelioma.
    Brčić L; Jakopović M; Brčić I; Klarić V; Milošević M; Sepac A; Samaržija M; Seiwerth S
    Virchows Arch; 2014 Dec; 465(6):679-85. PubMed ID: 25300229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytology of malignant pleural mesothelioma: Diagnostic criteria, WHO classification updates, and immunohistochemical staining markers diagnostic value.
    Shaker N; Wu D; Abid AM
    Diagn Cytopathol; 2022 Nov; 50(11):532-537. PubMed ID: 36069384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact on survival of nuclear atypia in epithelioid malignant mesothelioma.
    Mlika M; Limam M; Benzarti A; Mezni F
    Adv Respir Med; 2019; 87(2):90-95. PubMed ID: 31038719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproducibility of Malignant Pleural Mesothelioma Histopathologic Subtyping.
    Brcic L; Vlacic G; Quehenberger F; Kern I
    Arch Pathol Lab Med; 2018 Jun; 142(6):747-752. PubMed ID: 29509030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined grade and nuclear grade are prognosis predictors of epithelioid malignant peritoneal mesothelioma: a multi-institutional retrospective study.
    Benzerdjeb N; Dartigues P; Kepenekian V; Valmary-Degano S; Mery E; Averous G; Chevallier A; Laverriere MH; Villa I; Sallé FG; Villeneuve L; Glehen O; Isaac S; Hommell-Fontaine J;
    Virchows Arch; 2021 Nov; 479(5):927-936. PubMed ID: 34169365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel prognostic nomogram for predicting survival in diffuse pleural mesothelioma.
    Aksoy Y; Chou A; Mahjoub M; Sheen A; Sioson L; Ahadi MS; Gill AJ; Fuchs TL
    Pathology; 2023 Jun; 55(4):449-455. PubMed ID: 36842876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.